Drisapersen (sodium)
Drisapersen sodium, a antisense oligonucleotide, induces exon 51 skipping during dystrophin pre-mRNA splicing and allows synthesis of partially functional dystrophin in Duchenne muscular dystrophy (DMD) patients with amenable mutations.
Product Specifications
CAS Number
1181666-20-5
Product Name Alternative
Kyndrisa (sodium) ; GSK2402968A (sodium) ; PRO051 (sodium)
UNSPSC
12352208
Target
Others
Type
Oligonucleotides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/drisapersen-sodium.html
Purity
98.61
Solubility
10 mM in H2O
Smiles
[Drisapersen(sodium)]
Molecular Formula
C211H256N76Na19O119P19S19
Molecular Weight
6978 (free acid)
References & Citations
[1]Flanigan KM, Voit T, Rosales XQ, et al. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial. Neuromuscul Disord. 2014;24 (1) :16-24. |[2]Voit T, Topaloglu H, Straub V, et al. Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II) : an exploratory, randomised, placebo-controlled phase 2 study. Lancet Neurol. 2014;13 (10) :987-996.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP321922M 100 µg
Muted (BLOC1S5) (NM_201280) Human Recombinant Protein
Sign In for Pricing
View Details 
LC424636 20 µg
IL1 alpha (IL1A) (NM_000575) Human Over-expression Lysate
Sign In for Pricing
View Details 
